Skip to main content
. 2018 Feb 15;14(5):1275–1282. doi: 10.1080/21645515.2018.1426420

Figure 1.

Figure 1.

(a) Using the G10 and circulating strains (S1 strain) to test the neutralizing titer of antibodies induced by inactivated CAV16 vaccine produced by S-1 strain in mice. (b) Using the G10 and circulating strains (S1 strain and S5 strain) to test the neutralizing titer of antibodies induced by inactivated CAV16 vaccine produced by S1, S5 and S9 strain in goats. (c) Using the G10 and circulating strains (S1 strain and S5 strain) to test the neutralizing titer of antibodies induced by inactivated CAV16 vaccine produced by S1, S5 and S9 strain in rabbit. (d) Using the G10 and circulating strains (S1 strain and S5 strain) to test the neutralizing titer of antibodies in 10 convalescent sera from CVA16 infected patients. (e) Using ELISA to test the anti-CVA16 antibodies exist sera. The sera were diluted in 1:1000. (f) Using the WB to test anti-CVA16 antibodies exist in the sera.